medigraphic.com
ISSN 1561-3011 (Electronic)

2015, Number 3

<< Back Next >>

Rev Cubana Invest Bioméd 2015; 34 (3)

Twenty years of experience of the Nephrology Institute in performing percutaneous renal biopsy in adults

Bacallao MRA, López ML, Llerena FB, Heras MA, Dávalos IJM, Gutiérrez GF, González NL, Magrans BC

Language: Spanish
References: 21
Page: 213-223
PDF size: 177.45 Kb.


ABSTRACT

Introduction: percutaneous renal biopsy is a key element in the management of the chronic kidney disease in addition to having great value in the evaluation of acute kidney dysfunction and in making prognoses.
Objective: to identify the indications for percutaneos renal biopsy of native kidney in the Nephrology Institute from 1988 to 2007; the related complications, the diagnoses and their relationship with the form of presentation of the renal disease through a descriptive cross-sectional study.
Methods: primary data for this research work were gathered from the biopsy form. All the renal biopsies performed during the study years followed the Pathological Anatomy Department protocol. The statistical package SPSS 22.0 was used for data processing. Frequency distribution analysis, averages and standard deviation were used in the quantitative variables whereas the independence test served to identify possible associations of variables.
Results: the average age of patients was 35.9 years. In the group, 49.6 % were men. Fifty nine patients presented (3.9 %) presented with complications, mainly bleeding. Nephrotic syndrome (47 %) and nephritic syndrome (11.2 %) were the most common indications for biopsy. Glomerular diseases (91.3 %) predominated and primary glomerulopathies prevailed among them (75.3 %). The most common diagnoses were focal and segmental glomerulosclerosis (20.6 %) and mesangial proliferative glomerulopathy (16.8 %).
Conclusions: the most common indication of percutaneous renal biopsy is the nephrotic syndrome whereas the most frequent complication is bleeding. The usual diagnoses were focal and segmental glomerulosclerosis, mesangial proliferative glomerulopathy and lupus nephritis.


REFERENCES

  1. Dhaun N, Bellamy CO, Cattran DC, Kluth DC. Utility of renal biopsy in the clinical management of renal disease. Kidney Int. 2014;85:1039-48.

  2. Bacallao Méndez RA, Gómez Barry H, Badell Moore A, Llerena Ferrer B. LX años de biopsia renal percutánea: Cuba pionera en el mundo. Rev Cubana Med. 2011;50(4):465-9.

  3. Parrish AE. Complications of percutaneous renal biopsy: a review of 37 years’ experience. Clin Nephrol. 1992;38:135–41.

  4. Fogo AB. Approach to renal biopsy. Am J Kidney Dis. 2003;42: 826–36.

  5. Rivera F, López-Gómez JM, Pérez-García R. Clinicopathologic correlations of renal pathology in Spain. Kidney Int. 2004;66:898-905.

  6. Barbour S, Beaulieu M, Gill J, Djurdjev O, Reich H, Levin A, et al. An overview of the British Columbia Glomerulonephritis network and registry: integrating knowledge generation and translation within a single framework. BMC Nephrology. 2013;14:236.

  7. Roth R, Parikh S, Makey D. When size matters: diagnostic value of kidney biopsy according to the gauge of the biopsy needle. Am J Nephrol. 2013;37:249–54.

  8. Corapi KM, Chen JL, Balk EM. Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis. 2012;60:62–73.

  9. Pérez-Oliva J, Pérez R, Herrera R, Almaguer M, Brisquet E. Terapia renal de reemplazo dialítico en Cuba: tendencia durante los últimos 10 años. Rev Hab C. Médicas. 2012;11(3):424-33.

  10. Sabir S, Mubarak M, Ul-Haq I, Bibi A. Pattern of biopsy proven renal diseases at PNS SHIFA, Karachi: A cross-sectional survey. J Renal Inj Prev. 2013;2(4):133-7.

  11. Das U, Dakshinamurty KV, Prayaga A. Pattern of biopsy-proven renal disease in a single center of south India: 19 years experience. Indian J Nephrol. 2011;21(4):250–7.

  12. Parichatikanond P, Chawanasuntorapoj R, Shayakul C, Choensuchon B, Vasuvattakul S, Vareesangthip K, et al. An analysis of 3,555 cases of renal biopsy in Thailand. J Med Assoc Thai. 2006;89(Suppl 2):S106-11.

  13. Choi IJ, Jeong HJ, Han DS, Lee JS, Choi KH, Kang SW, et al. An analysis of 4,514 cases of renal biopsy in Korea. Yonsei Med J. 2001;42(2):247-54.

  14. Okpechi I, Swanepoel C, Duffield M, Mahala B, Wearne N, Alagbe S, et al. Patterns of renal disease in Cape Town South Africa: a 10-year review of a single-centre renal biopsy database. Nephrol Dial Transplant. 2011;26:1853–61.

  15. Nadium WK, Abdelwahab HH, Ibrahim MA, Shigidi MM. Histological pattern of primary glomerular diseases among adult Sudanese patients: A single center experience. Indian J Nephrol. 2013;23(3):176-9.

  16. Polito MG, Ribeiro de Moura LA, Mastroianni Kirsztajn G. An overview on frequency of renal biopsy diagnosis in Brazil: clinical and pathological patterns based on 9617 native kidney biopsies. Nephrol Dial Transplant. 2010;25:490-6.

  17. Sethi S, Zand L, Nasr SH, Glassock RJ, Fervenza FC. Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations. Clin Kidney J. 2014;7:531–7.

  18. Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F, et al. Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis. PLoS Genet. 2012;8(6)e1002765.

  19. Arias LF, Henao J, Giraldo RD, Carvajal N, Rodelo J, Arbeláez M, et al. Glomerular diseases in a Hispanic population: review of a regional renal biopsy database. Sao Paulo Med J. 2009;127(3):140-4.

  20. Chun MJ, Korbet SM, Schwartz MM, Lewis EJ. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol. 2004;15(8):2169-77.

  21. Kiffel J, Rahimzada Y, Trachtman H. Focal segmental glomerulosclerosis and chronic kidney disase in pediatric patients. Adv Chronic Kidney Dis. 2011;18(5):332–8.




2020     |     www.medigraphic.com